Global Radioisotopes in Medicine Market Growth 2025-2031
Description
The global Radioisotopes in Medicine market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.
Nuclear medicine uses radiation to provide diagnostic information about the functioning of a person"s specific organs, or to treat them. Diagnostic procedures using radioisotopes are now routine. Radiotherapy can be used to treat some medical conditions, especially cancer, using radiation to weaken or destroy particular targeted cells. The attributes of naturally decaying atoms, known as radioisotopes, give rise to several applications across many aspects of modern day life. There is widespread awareness of the use of radiation and radioisotopes in medicine, particularly for diagnosis (identification) and therapy (treatment) of various medical conditions.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
LP Information, Inc. (LPI) ' newest research report, the “Radioisotopes in Medicine Industry Forecast” looks at past sales and reviews total world Radioisotopes in Medicine sales in 2024, providing a comprehensive analysis by region and market sector of projected Radioisotopes in Medicine sales for 2025 through 2031. With Radioisotopes in Medicine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Radioisotopes in Medicine industry.
This Insight Report provides a comprehensive analysis of the global Radioisotopes in Medicine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Radioisotopes in Medicine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Radioisotopes in Medicine market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Radioisotopes in Medicine and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Radioisotopes in Medicine.
This report presents a comprehensive overview, market shares, and growth opportunities of Radioisotopes in Medicine market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Tc-99m
Cobalt-60
Iodine Radioisotopes
Others
Segmentation by Application:
Nuclear Therapy
Equipment Radioactive Source
Diagnosis
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
NRG
IRE
ANSTO
NTP Radioisotopes
China National Nuclear Corporation
Rosatom
Nordion
Eckert & Ziegler Strahlen
Polatom
SHINE Technologies
NorthStar Medical Radioisotopes
Key Questions Addressed in this Report
What is the 10-year outlook for the global Radioisotopes in Medicine market?
What factors are driving Radioisotopes in Medicine market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Radioisotopes in Medicine market opportunities vary by end market size?
How does Radioisotopes in Medicine break out by Type, by Application?
Please note: The report will take approximately 2 business days to prepare and deliver.
Nuclear medicine uses radiation to provide diagnostic information about the functioning of a person"s specific organs, or to treat them. Diagnostic procedures using radioisotopes are now routine. Radiotherapy can be used to treat some medical conditions, especially cancer, using radiation to weaken or destroy particular targeted cells. The attributes of naturally decaying atoms, known as radioisotopes, give rise to several applications across many aspects of modern day life. There is widespread awareness of the use of radiation and radioisotopes in medicine, particularly for diagnosis (identification) and therapy (treatment) of various medical conditions.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
LP Information, Inc. (LPI) ' newest research report, the “Radioisotopes in Medicine Industry Forecast” looks at past sales and reviews total world Radioisotopes in Medicine sales in 2024, providing a comprehensive analysis by region and market sector of projected Radioisotopes in Medicine sales for 2025 through 2031. With Radioisotopes in Medicine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Radioisotopes in Medicine industry.
This Insight Report provides a comprehensive analysis of the global Radioisotopes in Medicine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Radioisotopes in Medicine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Radioisotopes in Medicine market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Radioisotopes in Medicine and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Radioisotopes in Medicine.
This report presents a comprehensive overview, market shares, and growth opportunities of Radioisotopes in Medicine market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Tc-99m
Cobalt-60
Iodine Radioisotopes
Others
Segmentation by Application:
Nuclear Therapy
Equipment Radioactive Source
Diagnosis
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
NRG
IRE
ANSTO
NTP Radioisotopes
China National Nuclear Corporation
Rosatom
Nordion
Eckert & Ziegler Strahlen
Polatom
SHINE Technologies
NorthStar Medical Radioisotopes
Key Questions Addressed in this Report
What is the 10-year outlook for the global Radioisotopes in Medicine market?
What factors are driving Radioisotopes in Medicine market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Radioisotopes in Medicine market opportunities vary by end market size?
How does Radioisotopes in Medicine break out by Type, by Application?
Please note: The report will take approximately 2 business days to prepare and deliver.
Table of Contents
107 Pages
- *This is a tentative TOC and the final deliverable is subject to change.*
- 1 Scope of the Report
- 2 Executive Summary
- 3 Global by Company
- 4 World Historic Review for Radioisotopes in Medicine by Geographic Region
- 5 Americas
- 6 APAC
- 7 Europe
- 8 Middle East & Africa
- 9 Market Drivers, Challenges and Trends
- 10 Manufacturing Cost Structure Analysis
- 11 Marketing, Distributors and Customer
- 12 World Forecast Review for Radioisotopes in Medicine by Geographic Region
- 13 Key Players Analysis
- 14 Research Findings and Conclusion
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
